Lycopene & Prostate Cancer

As regular readers of this column already know,progression of prostate cancer in these men.
recent research data has been quite unkind to manyWhile this was a very small pilot study, with limited
vitamins and other dietary supplements that werestatistical power, its results are nonetheless
previously thought to have a potential role in diseasedisappointing. Previous studies of lycopene and
prevention. While the vitamin and supplementsprostate cancer have largely relied upon so-called "in
industry remains a multi-billion dollar business, largevitro" research on prostate cancer cells growing in a
prospective clinical research trials in recent yearslaboratory dish, or on dietary surveys in epidemiology
have, repeatedly, shown no health benefits fromstudies. These are popular methodologies of cancer
taking vitamin supplements, and in some cases,prevention and treatment research because they are
certain vitamin supplements appear to actuallyquick and inexpensive to perform. But the vast
worsen health.majority of the findings of these types of lower-level
As in so many other cases, laboratory researchresearch studies are, unfortunately, never confirmed
studies using cancer cells growing in Petrie dishesby high-level prospective, randomized clinical research
have previously suggested that lycopene, a membertrials.
of the Vitamin A family, might be toxic to prostateGiven the very small number of patients enrolled in
cancer cells. This, predictably, has spurred tens ofthis pilot trial, and the relatively short duration of
thousands of men to take lycopene supplements infollow-up, a larger, placebo-controlled, prospective,
hopes of preventing prostate cancer. However, arandomized clinical trial with lycopene should be
small new prospective clinical and laboratory researchundertaken. The men in this small pilot study also had
trial, just published in the Journal of Urology, suggestsadvanced prostate cancer that had become resistant
that lycopene may not offer any clinical benefit as ato current treatments, and so it might be helpful to
treatment adjunct in men with advanced prostateperform a larger clinical trial with men who have
cancer.intermediate-stage prostate cancer, in the hope that
In this small pilot study, 17 adult patients witha more modest benefit from lycopene, if it exists,
prostate cancer refractory to other treatments weremight be identified. For now, however, the clinical
given 15 milligrams of lycopene per day for 6 months.evidence remains extremely weak that lycopene has
During the course of this study, both the clinicalany useful role to play in either the prevention or
progression of these patients' prostate cancers andtreatment of prostate cancer (indeed, I stopped
the level of prostate specific antigen (PSA) in theirtaking lycopene, myself, several years ago, when I
blood were monitored. Unfortunately, there was noconcluded that the available clinical data did not
clinically detectable benefit of lycopene on thesupport its use as a cancer prevention agent).